Mr. Lynch Brings 23+ Years of Global Life Science Experience to BioAgilytix’s Executive Leadership Team in Support of the Company’s Continued Rapid Growth
BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has welcomed Todd Lynch, CPA to its executive leadership team as SVP and Chief Financial Officer. With more than 23 years of experience in biotechnology, big pharma, clinical diagnostics, and contract research organizations ranging from pre-revenue to Fortune 500 companies, Mr. Lynch will play a key role in the development and execution of strategies to support BioAgilytix’s rapid growth. His previous experience at companies including GlaxoSmithKline, Inveresk Research, and most recently, Metabolon, will inform his perspective as he oversees the financial, IT, and HR aspects of BioAgilytix as the company continues to scale. “BioAgilytix has been experiencing incredible growth, which I attribute primarily to the quality of the team they have in place, as well as their customer focus,” said Lynch. “Their employee retention rate, over 90%, is one of the best in the industry – and the level of quality in their science, data, and people is what really attracted me to the company. I’m excited to join the team and help plot the course to further growth and success.”
Jim Datin, Chief Executive Officer of BioAgilytix, commented that “we are thrilled to bring Todd on board as an integral member of our leadership team. He has played a valuable strategic role in his past CFO positions at clinical diagnostics and contract research organizations, and he understands the opportunities and challenges facing a rapidly growing company like ours. We know he will bring the veteran insights we need to scale successfully, while continuing to meet and exceed the demands of the customers who entrust BioAgilytix with their most critical large molecule drug programs.”
“I’m looking forward to applying my global life science background and experience in growth-oriented companies to this new opportunity, and helping the BioAgilytix team achieve their vision for success,” said Lynch.
BioAgilytix is a leading bioanalytical testing laboratory specializing in large molecule bioanalysis. Located in North Carolina’s Research Triangle, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development and release testing of biologics across a number of industries and disease states. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, spirit-of-GLP, and GLP, as well as product release testing under GMP.
BioAgilytix’s team of highly experienced scientific and QA professionals ensures high quality science, sample and data integrity, and regulatory compliance through all phases of clinical development, and is a trusted partner to 6 of the top 10 global pharmaceutical and biotech companies. For more information, visit www.bioagilytix.com.